Agilent Technologies(A)
Search documents
Agilent (A) Reliance on International Sales: What Investors Need to Know
ZACKS· 2024-08-26 14:15
Have you assessed how the international operations of Agilent Technologies (A) performed in the quarter ended July 2024? For this scientific instrument maker, possessing an expansive global footprint, parsing the trends of international revenues could be critical to gauge its financial resilience and growth prospects.The global economy today is deeply interlinked, making a company's engagement with international markets a critical factor in determining its financial success and growth path. It has become es ...
Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi
Seeking Alpha· 2024-08-23 00:44
hapabapa Agilent Technologies (NYSE:A) offers instruments, consumables, software and services to life sciences, diagnostics and applied chemical markets. Agilent has made significant efforts in transforming its business towards growth areas including biopharma, polyfluoroalkyl substances (PFAS) testing and advanced materials for semiconductor. I am initiating a ‘Buy’ rating with a one-year target price of $160 per share. Growing Biopharma, PFAS & Advanced Materials Agilent offers workflow solutions for ...
Agilent (A) Q3 Earnings & Revenues Beat Estimates, Fall Y/Y
ZACKS· 2024-08-22 17:51
Agilent Technologies (A) has delivered third-quarter fiscal 2024 earnings of $1.32 per share, which beat the Zacks Consensus Estimate by 5.6%. However, the bottom line decreased 8% from the year-ago quarter. Revenues of $1.58 billion beat the Zacks Consensus Estimate of $1.56 billion. The top line declined 5.6% on a reported basis and 4.4% on a core basis from the year-ago quarter. The decline was attributed to broad-based weakness across the Pharma, Food, Chemical and Advanced Materials, and Academic and G ...
These Analysts Boost Their Forecasts On Agilent After Strong Earnings
Benzinga· 2024-08-22 16:08
Agilent Technologies, Inc. A posted better-than-expected third-quarter earnings and issued upbeat fourth-quarter guidance on Wednesday.Revenue fell 5.6% Y/Y to $1.58 billion, beating the consensus of $1.56 billion. By segment, the Life Sciences and Applied Markets Group (LSAG) segment reported revenue of $782 million, down 8% Y/Y (-7% Y/Y core), with an operating margin of 28.4%. Adjusted EPS of $1.32 surpassed the street view of $1.26.Agilent said it sees fourth-quarter revenue of $1.641 billion – $1.691 b ...
A Stock Earnings: Agilent Technologies Beats EPS, Beats Revenue for Q3 2024
Investor Place· 2024-08-22 00:53
Agilent Technologies (NYSE:A) just reported results for the third quarter of 2024. Agilent Technologies reported earnings per share of $1.32. This was above the analyst estimate for EPS of $1.26. The company reported revenue of $1.58 billion. This was 1.15% better than the analyst estimate for revenue of $1.56 billion. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings pe ...
Agilent Technologies(A) - 2024 Q3 - Earnings Call Transcript
2024-08-22 00:10
Agilent Technologies, Inc. (NYSE:A) Q3 2024 Earnings Conference Call August 21, 2024 4:30 PM ET Company Participants Conference Call Participants Operator Ladies and gentlemen, welcome to the Agilent Technologies Q3 2024 Earnings Call. My name is Regina and I will be coordinating your call today. [Operator Instructions] I will now hand you over to your host, Parmeet Ahuja, to begin. Please go ahead. Parmeet Ahuja Thank you and welcome, everyone, to Agilent's conference call for the Third Quarter of Fiscal Y ...
Agilent (A) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2024-08-21 23:00
For the quarter ended July 2024, Agilent Technologies (A) reported revenue of $1.58 billion, down 5.6% over the same period last year. EPS came in at $1.32, compared to $1.43 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $1.56 billion, representing a surprise of +0.99%. The company delivered an EPS surprise of +5.60%, with the consensus EPS estimate being $1.25.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Str ...
Agilent Technologies (A) Q3 Earnings and Revenues Beat Estimates
ZACKS· 2024-08-21 22:15
Agilent Technologies (A) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $1.43 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 5.60%. A quarter ago, it was expected that this scientific instrument maker would post earnings of $1.19 per share when it actually produced earnings of $1.22, delivering a surprise of 2.52%. Over the last four ...
Agilent Technologies(A) - 2024 Q3 - Quarterly Results
2024-08-21 20:06
Exhibit 99.1 Agilent Reports Third-Quarter Fiscal Year 2024 Financial Results Delivers better-than-expected performance; raises mid-point of guidance Highlights • Revenue of $1.58 billion, down 5.6% reported and 4.4% core from the third quarter of 2023. • GAAP net income of $282 million; earnings per share (EPS) of $0.97, up 155% from the third quarter of 2023. (2) • Non-GAAP net income of $385 million; EPS of $1.32, down 8% from the third quarter of 2023. (3) • Full-year revenue outlook revised at $6.450 b ...
Agilent (A) Boosts LSAG Segment With J&W 5Q GC/MS Columns
ZACKS· 2024-08-20 15:31
Agilent Technologies (A) introduced an advanced gas chromatography/mass spectrometry (GC/MS) column technology product namely J&W 5Q GC/MS Columns, in order to expand its Life Sciences and Applied Markets (LSAG) segment.The new GC/MS columns are designed to enhance GC/MS workflows and boost system performance in challenging conditions. With the help of J&W 5Q GC/MS Columns, Agilent strives to meet the demands of modern analytical laboratories. The new columns reduce the frequency of column changes and impro ...